SK바이오사이언스, 상장 이후에도 주가 상승 여력 크다 mt.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mt.co.kr Daily Mail and Mail on Sunday newspapers.
March 16 2021
He and other leading Democrats talk about what s ahead for health care after Biden s plan.
U.S. Sen. Ron Wyden says among the next steps Congress must take on health care are to lower the soaring cost of some medications specifically insulin and restore the ability of the federal government to negotiate drug prices for Medicare.
The Oregon Democrat joined the chairs of two other congressional committees Tuesday, March 16, on a conference call sponsored by Protect Our Care, a coalition of progressive groups formed in late 2016 to defend the Affordable Care Act against Republican attempts to repeal it.
Wyden, Washington Sen. Patty Murray and New Jersey Rep. Frank Pallone discussed in detail what President Joe Biden s $1.9 trillion pandemic recovery plan does for health care. The plan broadens federal subsidies for health insurance premiums under the 2010 law, often known as Obamacare after the president who signed it. It also extends federal incentives to
Study links green communities to lower stroke risk
Michael Merschel, American Heart Association News
March 17, 2021
FacebookTwitterEmail
The greener the neighborhood, the lower the stroke risk, a new study suggests.
Researchers matched images gathered from space to health data from residents to come up with their findings. The work adds to evidence that shows where someone lives affects their health, said study co-author Dr. William Aitken. He is a cardiology fellow at the University of Miami and Jackson Memorial Hospital in Florida. There s a lot of evidence that our natural environment does influence health, and we wanted to look at it particularly with stroke, Aitken said.
(0)
Study meets primary and key secondary objectives with positive impact and favorable overall safety profile in 21 heavily pre-treated and immunocompromised patients with steroid-resistant, gastrointestinal-predominant aGvHD following stem cell transplantation
Results in line with previously observed data from a larger patient population treated with MaaT013 as part of an early access program
MaaT013 expected to advance into pivotal Phase 3 program MaaT Pharma announced today positive topline results from its Phase 2 clinical trial evaluating lead microbiome ecosystem therapy, MaaT013, in a high-risk patient population with grade III-IV steroid-refractory, gastrointestinal-predominant acute graft-versus-host disease (SR-GI-aGvHD). The study met its primary endpoint of clinical efficacy, demonstrating a combined 33.3% complete response rate (CR) or very good partial response rate (VGPR) at day 28. In addition, the overall response rate (ORR) was 38.1% at day 28 and the be
(2)
Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal knee replacement implants enable expedited surgical time and reduce length of hospital stay.
BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants. Importantly, this study was independently performed with no sponsorship or funding from Conformis.
The new abstract was presented by authors at the Orthopaedic Research Society 2021 Annual Meeting (ORS 2021 Annual Meeting), held in February 2021:
Custom-designed total knee arthroplasty is cost-effective in comparison to a standard implant (https://www.ors.org/Transactions/67/980.pdf), Navin Fernando MD, Ann Chancellor CCRC, Paul Manner MD, University of Washingt